Evidence map›Paper›PMID 19780660›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2009

The A, B, BI, and Cs of Clostridium difficile.

Erik R Dubberke

Registry-linked trialAbstract readEditorialComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01552668 (The Effect of a Twice Daily, 200 mg Dose of Oral Fidaxomicin Compared to Placebo on Risk of Acquiring C. Difficile and Developing C. Difficile Infection), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01552668 phase4withdrawnnot on this mapstarted 2012, after this paper: background citation

The Effect of a Twice Daily, 200 mg Dose of Oral Fidaxomicin Compared to Placebo on Risk of Acquiring C. Difficile and Developing C. Difficile Infection (CDI) in High Risk Patients

TypeinterventionalSponsorWashington University School of MedicineRan2012 to 2013Enrolled0ConditionsClostridium Difficile InfectionArmsFidaxomicin, Placebo
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Erik R Dubberke

Funding

C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTSK23AI065806 · NIAID · WASHINGTON UNIVERSITY · PI DUBBERKE, ERIK R · 2009 to 2011
$374k
NIAID NIH HHS K23 AI065806NIAID NIH HHS L30 AI062141
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial Typing TechniquesClostridioides difficileCross InfectionEnterocolitis, PseudomembranousGenotypeHumansIncidenceInfection ControlMolecular Epidemiology

Identifiers

PMID19780660
PMCPMC3649764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.